- Home
- ESCA vs ARCT Comparison
ESCA vs ARCT Comparison
Compare ESCA & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESCA | ARCT |
|---|---|---|
| Founded | 1922 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 257.2M | 217.7M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ESCA | ARCT |
|---|---|---|
| Price | $18.63 | $7.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $24.11 |
| AVG Volume (30 Days) | 23.1K | ★ 382.0K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.50% | N/A |
| EPS Growth | 6.45 | ★ 20.00 |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $180,541,000.00 | $82,031,000.00 |
| Revenue This Year | $4.15 | N/A |
| Revenue Next Year | N/A | $12.77 |
| P/E Ratio | $58.22 | ★ N/A |
| Revenue Growth | ★ 2.71 | N/A |
| 52 Week Low | $11.41 | $5.85 |
| 52 Week High | $21.32 | $24.14 |
Technical Indicators
Market Signals| Indicator | ESCA | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 49.40 | 46.06 |
| Support Level | $17.33 | $6.82 |
| Resistance Level | $18.72 | $7.94 |
| Average True Range (ATR) | 0.57 | 0.42 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 43.19 | 39.86 |
Price Performance
Historical ComparisonAbout ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting, and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are the United States, Canada, Australia, and Other regions.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.